510(k) Report

510(k) · Cleared

Recalled · Class II · 2022

BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit

K180438510(k) SpecialCleared Mar 20, 201828-day reviewClass II21 CFR 866.3328Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Bd · PSZ Devices Detecting Influenza A, B, And C Virus Antigens

Cleared on Mar 20, 2018 as substantially equivalent to K112277 (Becton, Dickinson and Company, 2011) and 4 other predicates after a 28-day review. Its family tree reaches back 12 generations to 1990. 5 later devices descend from it. It has been recalled 2 times.

Decided
Mar 20, 2018
Review
28 days
Class
Class II
Product code
PSZ
Recalls
2
Predicates
5

Its longest line of descent runs back 12 generations to K902609 (1990). 14 ancestors in all. 5 later devices descend from it, 2 citing it directly.

  1. Root · 12 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 8 generations between
  3. 3 generations backK151291 BD Veritor (TM) System for the Rapid Detection of Flu A+BBecton, Dickinson and Company · 2015
  4. 2 generations backK152870 BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson and Co. · 2015
  5. 1 generation backK160161 BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson & CO · 2016
  6. This deviceK180438 BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBd · 2018
  7. Descendant · cites it directly · 2 of its ownK223016 BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitBd · 2023
  8. Descendant · 2 generations on · 1 of its ownK232434 BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived KitBd · 2023
  9. Descendant · cites it directly · 1 of its ownK191514 CareStart Flu A&B PlusAccess Bio, Inc. · 2020
  10. Descendant · 3 generations on · 0 of its ownK252283 Nano-Check Influenza A+B TestNano-Ditech Corporation · 2026
  11. Descendant · 2 generations on · 0 of its ownK250398 Innovita Flu A/B Antigen Rapid TestInnovita (Tangshan) Biological Technology Co., Ltd. · 2025
Show all 12 generations
  1. Root · 12 generations backK902609 Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic · 1990
  2. 11 generations backK981651 AB Flu OiaBiostar, Inc. · 1998
  3. 10 generations backK023556 Flu Oia a/B Test KitThermo Biostar, Inc. · 2003 · Recalled
  4. 9 generations backK031899 Quickvue Influenza a+B TestQuidel Corp. · 2003
  5. 8 generations backK053146 Quickvue Influenza a + B TestQuidel Corp. · 2005
  6. 7 generations backK092698 Quickvue Influenza a+B TestQuidel Corp. · 2009
  7. 6 generations backK112277 BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company · 2011 · Recalled
  8. 5 generations backK132259 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
  9. 4 generations backK132692 BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company · 2013
  10. 3 generations backK151291 BD Veritor (TM) System for the Rapid Detection of Flu A+BBecton, Dickinson and Company · 2015
  11. 2 generations backK152870 BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson and Co. · 2015
  12. 1 generation backK160161 BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson & CO · 2016
  13. This deviceK180438 BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBd · 2018

Most influential descendants

Showing 5 of 5 · See all
  • K223016BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitBd · 2023 · cites it directly2descendants
  • K232434BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived KitBd · 2023 · 2 generations on1descendant
  • K191514CareStart Flu A&B PlusAccess Bio, Inc. · 2020 · cites it directly1descendant
  • K252283Nano-Check Influenza A+B TestNano-Ditech Corporation · 2026 · 3 generations on0descendants
  • K250398Innovita Flu A/B Antigen Rapid TestInnovita (Tangshan) Biological Technology Co., Ltd. · 2025 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−12K902609Directigen Flu aBd Becton Dickinson Vacutainer Systems Preanalytic1990—
−11K981651AB Flu OiaBiostar, Inc.1998—
−10K023556Flu Oia a/B Test KitThermo Biostar, Inc.20031
−9K031899Quickvue Influenza a+B TestQuidel Corp.2003—
−8K053146Quickvue Influenza a + B TestQuidel Corp.2005—
−7K092698Quickvue Influenza a+B TestQuidel Corp.2009—
−6K112277BD Veritor (TM) System for Rapid Detection of Flu a+BBecton, Dickinson and Company20111
−5K132259BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company2013—
−4K132692BD Veritor System for the Rapid Detection of Flu a+BBecton, Dickinson and Company2013—
−3K151291BD Veritor (TM) System for the Rapid Detection of Flu A+BBecton, Dickinson and Company2015—
−2K152870BD Veritor System for the Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson and Co.2015—
−1K160161BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBecton, Dickinson & CO2016—
0 (this device)K180438BD Veritor System for Rapid Detection of Flu A + B CLIA waived kitBd2018—
+1K223016BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitBd2023—
+2K232434BD Veritor™ System for Rapid Detection of Flu A+B CLIA Waived KitBd2023—
+1K191514CareStart Flu A&B PlusAccess Bio, Inc.2020—
+3K252283Nano-Check Influenza A+B TestNano-Ditech Corporation2026—
+2K250398Innovita Flu A/B Antigen Rapid TestInnovita (Tangshan) Biological Technology Co., Ltd.2025—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199910
200010

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202010
202320
202510
202610
FIG. 1 — Lineage of K180438, 1990–2026Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in PSZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new PSZ device

  1. #1 K252283 Nano-Check Influenza A+B Testscore 14.9 · 15 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K112277BD Veritor (TM) System for Rapid Detection of Flu a+B
Summary page 4
…Microbiology PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277, k132259, k132692, k151291, k160161) INTENDED USE : The BD Veritor System for Rapid Detection…
Becton, Dickinson and Company20111
*K132259BD Veritor System for the Rapid Detection of Flu a+B
Summary page 4
…Microbiology PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277, k132259, k132692, k151291, k160161) INTENDED USE : The BD Veritor System for Rapid Detection of Flu A…
Becton, Dickinson and Company2013—
*K132692BD Veritor System for the Rapid Detection of Flu a+B
Summary page 4
…Microbiology PREDICATE DEVICES : BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277, k132259, k132692, k151291, k160161) INTENDED USE : The BD Veritor System for Rapid Detection of Flu A+B CLIA w…
Becton, Dickinson and Company2013—
*K151291BD Veritor (TM) System for the Rapid Detection of Flu A+B
Summary page 4
…BD Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277, k132259, k132692, k151291, k160161) INTENDED USE : The BD Veritor System for Rapid Detection of Flu A+B CLIA waived assay is a rapid chromatographic immu…
Becton, Dickinson and Company2015—
*K160161BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit
Summary page 4
…D Veritor™ System for Rapid Detection of Flu A+B CLIA waived kit (k112277, k132259, k132692, k151291, k160161) INTENDED USE : The BD Veritor System for Rapid Detection of Flu A+B CLIA waived assay is a rapid chromatographic immunoassay f…
Becton, Dickinson & CO2016—

Also cleared against K112277: 7 other devices →

What descends from it? (5)

2 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K223016BD VeritorTM System for Rapid Detection of Flu A+B CLIA-Waived KitBd20232
K191514CareStart Flu A&B PlusAccess Bio, Inc.20201

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Jan 5, 2022Class IIZ-0630-2022Under Investigation by firmMay have the potential to overheat and/or cause fire, the issue can occur when an unauthorized alternative AC power adapter, and not the one provided by BD is used to power the instrument.
Apr 3, 2019Class IIZ-1313-2019Under Investigation by firmBackground calibration has the potential to cause false positive or false negative test results. An incorrect test result with the BD Veritor System could lead to possible misdiagnosis and inappropriate treatment

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 28 years and passes through 8 companies; a new generation was cleared every 2.1 years on median.
  • 2 of the 14 ancestors have a recall of any class.
  • Of its descendants, K223016 (Bd, 2023) has gone furthest, with 2 descendants of its own.
  • 7 other devices also cite its predicate K112277.

How does its category compare?

All PSZ devices

PSZ Devices Detecting Influenza A, B, And C Virus Antigens: FDA decisions, review times, recalls and adverse event reports over 20 years. 2018, this device’s year, is highlighted.

FDA decisions per year · PSZ

2in 2025

2007: 22008: 12009: 72010: 52011: 32012: 22013: 82014: 12015: 42016: 32017: 32018: 52020: 22023: 22025: 22026 (partial year): 2
2007high 8 (2013) · low 0 (2019)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · PSZ

28in 2018

2009: 20 days median2010: 29 days median2011: 80 days median2013: 28 days median2015: 27 days median2016: 29 days median2017: 200 days median2018: 28 days median
2007high 200 (2017) · low 20 (2009)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · PSZ

1in 2022

2020: 12022: 1
2007high 1 (2020) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · PSZ

60in 2025

2018: 12019: 12020: 52021: 422022: 102023: 122024: 162025: 60
2007high 60 (2025) · low 0 (2007)2025

MAUDE reports naming product code PSZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20072—00
20081—00
200972000
201052900
201138000
20122—00
201382800
20141—00
201542700
201632900
2017320000
201852801
20190—01
20202—15
20210—042
20220—110
20232—012
20240—016
20252—060
20262—0—

What is it indicated for?

The BD Veritor System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B (also referred to as the BD Veritor System and BD Veritor System Flu A+B) is a differentiated test, such that influenza A viral antigens can be distinguished…

Read the full statement (348 words)

The BD Veritor System for Rapid Detection of Flu A+B is a rapid chromatographic immunoassay for the direct and qualitative detection of influenza A and B viral nucleoprotein antigens from nasal and nasopharyngeal swabs of symptomatic patients. The BD Veritor System for Rapid Detection of Flu A+B (also referred to as the BD Veritor System and BD Veritor System Flu A+B) is a differentiated test, such that influenza A viral antigens can be distinguished from influenza B viral antigens from a single processed sample using a single device. The test is to be used as an aid in the diagnosis of influenza A and B viral infections. A negative test is presumptive and it is recommended that these results be confirmed by viral culture or an FDA-cleared influenza A and B molecular assay. Outside the U.S., a negative test is presumptive and it is recommended that these results be confirmed by viral culture or a molecular assay cleared for diagnostic use in the country of use. FDA has not cleared this device for use outside of the U.S. Negative test results do not preclude influenza viral infection and should not be used as the sole basis for treatment or other patient management decisions. The test is not intended to detect influenza C antigens.

Performance characteristics for influenza A and B were established during January through March of 2011 when influenza viruses A/2009 H1N1, A/H3N2, B/Victoria lineage, and B/Yamagata lineage were the predominant influenza viruses in circulation according to the Morbidity and Mortality Weekly Report from the CDC entitled “Update: Influenza Activity—United States, 2010-2011 Season, and Composition of the 2011-2012 Influenza Vaccine.” Performance characteristics may vary against other emerging influenza viruses.

If infection with a novel influenza virus is suspected based on current clinical and epidemiological screening criteria recommended by public health authorities, specimens should be collected with appropriate infection control precautions for novel virulent influenza viruses and sent to the state or local health department for testing. Virus culture should not be attempted in these cases unless a BSL 3+ facility is available to receive and culture specimens.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K180438: BD Veritor System for Rapid Detection of Flu A + B CLIA waived kit.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K180438

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026